Ex vivo effect of gold nanoparticles on porcine synovial membrane

References

• Higby GJ. Gold in medicine: a review of its use in the West before 1900. Gold Bull 1982; 15:130 - 40; http://dx.doi.org/10.1007/BF03214618; PMID: 11614517
   PubMedGoogle Scholar
• Rau R. Have traditional DMARDs had their day? Effectiveness of parenteral gold compared to biologic agents. Clin Rheumatol 2005; 24:189 - 202; http://dx.doi.org/10.1007/s10067-004-0869-8; PMID: 15940552
   PubMed Web of Science ®Google Scholar
• Hamilton J, McInnes IB, Thomson EA, Porter D, Hunter JA, Madhok R, et al. Comparative study of intramuscular gold and methotrexate in a rheumatoid arthritis population from a socially deprived area. Ann Rheum Dis 2001; 60:566 - 72; http://dx.doi.org/10.1136/ard.60.6.566; PMID: 11350844
   PubMed Web of Science ®Google Scholar
• Lehman AJ, Esdaile JM, Klinkhoff AV, Grant E, Fitzgerald A, Canvin J, METGO Study Group. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study. Arthritis Rheum 2005; 52:1360 - 70; http://dx.doi.org/10.1002/art.21018; PMID: 15880810
   PubMed Web of Science ®Google Scholar
• Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010; 69:964 - 75; http://dx.doi.org/10.1136/ard.2009.126532; PMID: 20444750
   PubMed Web of Science ®Google Scholar
• Sander O, Herborn G, Bock E, Rau R. Prospective six year follow up of patients withdrawn from a randomised study comparing parenteral gold salt and methotrexate. Ann Rheum Dis 1999; 58:281 - 7; http://dx.doi.org/10.1136/ard.58.5.281; PMID: 10225812
   PubMed Web of Science ®Google Scholar
• Nejrup K, Olivarius NdeF, Jacobsen JL, Siersma V. Randomised controlled trial of extraarticular gold bead implantation for treatment of knee osteoarthritis: a pilot study. Clin Rheumatol 2008; 27:1363 - 9; http://dx.doi.org/10.1007/s10067-008-0918-9; PMID: 18500437
   PubMed Web of Science ®Google Scholar
• Jaeger GT, Larsen S, Søli N, Moe L. Double-blind, placebo-controlled trial of the pain-relieving effects of the implantation of gold beads into dogs with hip dysplasia. Vet Rec 2006; 158:722 - 6; http://dx.doi.org/10.1136/vr.158.21.722; PMID: 16731702
   PubMed Web of Science ®Google Scholar
• Danscher G. In vivo liberation of gold ions from gold implants. Autometallographic tracing of gold in cells adjacent to metallic gold. Histochem Cell Biol 2002; 117:447 - 52; http://dx.doi.org/10.1007/s00418-002-0400-8; PMID: 12029492
   PubMed Web of Science ®Google Scholar
• Tsai CY, Shiau AL, Chen SY, Chen YH, Cheng PC, Chang MY, et al. Amelioration of collagen-induced arthritis in rats by nanogold. Arthritis Rheum 2007; 56:544 - 54; http://dx.doi.org/10.1002/art.22401; PMID: 17265489
   PubMed Web of Science ®Google Scholar
• Leonavičienė L, Kirdaitė G, Bradūnaitė R, Vaitkienė D, Vasiliauskas A, Zabulytė D, et al. Effect of gold nanoparticles in the treatment of established collagen arthritis in rats. Medicina (Kaunas) 2012; 48:91 - 101; PMID: 22491387
   PubMed Web of Science ®Google Scholar
• Dykman LA, Khlebtsov NG. Gold nanoparticles in biology and medicine: recent advances and prospects. Acta Naturae 2011; 3:34 - 55; PMID: 22649683
   PubMed Web of Science ®Google Scholar
• Edwards SH. Intra-articular drug delivery: the challenge to extend drug residence time within the joint. Vet J 2011; 190:15 - 21; http://dx.doi.org/10.1016/j.tvjl.2010.09.019; PMID: 20947396
   PubMed Web of Science ®Google Scholar
• Butoescu N, Jordan O, Doelker E. Intra-articular drug delivery systems for the treatment of rheumatic diseases: a review of the factors influencing their performance. Eur J Pharm Biopharm 2009; 73:205 - 18; http://dx.doi.org/10.1016/j.ejpb.2009.06.009; PMID: 19545624
   PubMed Web of Science ®Google Scholar
• Squier CA, Mantz MJ, Schlievert PM, Davis CC. Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa. J Pharm Sci 2008; 97:9 - 21; http://dx.doi.org/10.1002/jps.21077; PMID: 17721937
   PubMed Web of Science ®Google Scholar
• Blikslager AT, Moeser AJ, Gookin JL, Jones SL, Odle J. Restoration of barrier function in injured intestinal mucosa. Physiol Rev 2007; 87:545 - 64; http://dx.doi.org/10.1152/physrev.00012.2006; PMID: 17429041
   PubMed Web of Science ®Google Scholar
• Walsh AJ, Poole KM, Duvall CL, Skala MC. Ex vivo optical metabolic measurements from cultured tissue reflect in vivo tissue status. J Biomed Opt 2012; 17:116015; http://dx.doi.org/10.1117/1.JBO.17.11.116015; PMID: 23117810
   PubMed Web of Science ®Google Scholar
• Davies J. Potential Advantages of Using Biomimetic Alternatives. In: Davies J, ed. Replacing Animal Models: A practical Guide to Creating and Using Culture-based Biomimetic Alternatives: John Wiley & Sons, 2012.
   Google Scholar
• Morton AJ, Campbell NB, Gayle JM, Redding WR, Blikslager AT. Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis. Res Vet Sci 2005; 78:189 - 92; http://dx.doi.org/10.1016/j.rvsc.2004.07.006; PMID: 15563928
   PubMed Web of Science ®Google Scholar
• Sutton S, Clutterbuck A, Harris P, Gent T, Freeman S, Foster N, et al. The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis. Vet J 2009; 179:10 - 24; http://dx.doi.org/10.1016/j.tvjl.2007.08.013; PMID: 17911037
   PubMed Web of Science ®Google Scholar
• Sabaratnam S, Arunan V, Coleman PJ, Mason RM, Levick JR. Size selectivity of hyaluronan molecular sieving by extracellular matrix in rabbit synovial joints. J Physiol 2005; 567:569 - 81; http://dx.doi.org/10.1113/jphysiol.2005.088906; PMID: 15961430
   PubMed Web of Science ®Google Scholar
• Bergen JM, von Recum HA, Goodman TT, Massey AP, Pun SH. Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery. Macromol Biosci 2006; 6:506 - 16; http://dx.doi.org/10.1002/mabi.200600075; PMID: 16921538
   PubMed Web of Science ®Google Scholar
• Blikslager AT, Roberts MC, Argenzio RA. Prostaglandin-induced recovery of barrier function in porcine ileum is triggered by chloride secretion. Am J Physiol 1999; 276:G28 - 36; PMID: 9886975
   PubMed Web of Science ®Google Scholar
• Huether MJ, Lin G, Smith DM, Murtaugh MP, Molitor TW. Cloning, sequencing and regulation of an mRNA encoding porcine interleukin-1 beta. Gene 1993; 129:285 - 9; http://dx.doi.org/10.1016/0378-1119(93)90281-7; PMID: 8325511
   PubMed Web of Science ®Google Scholar
• Pecchi E, Priam S, Mladenovic Z, Gosset M, Saurel AS, Aguilar L, et al. A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E₂ and matrix metalloproteinases synthesis in interleukin-1β-stimulated osteoblasts. Osteoarthritis Cartilage 2012; 20:127 - 35; http://dx.doi.org/10.1016/j.joca.2011.12.002; PMID: 22179028
   PubMed Web of Science ®Google Scholar
• Chandrasekhar S, Harvey AK, Hrubey PS. Intra-articular administration of interleukin-1 causes prolonged suppression of cartilage proteoglycan synthesis in rats. Matrix 1992; 12:1 - 10; http://dx.doi.org/10.1016/S0934-8832(11)80099-5; PMID: 1560785
   PubMedGoogle Scholar
• Goodstone NJ, Hardingham TE. Tumour necrosis factor alpha stimulates nitric oxide production more potently than interleukin-1beta in porcine articular chondrocytes. Rheumatology (Oxford) 2002; 41:883 - 91; http://dx.doi.org/10.1093/rheumatology/41.8.883; PMID: 12154205
   PubMed Web of Science ®Google Scholar
• Shimokawa H, Ito A, Fukumoto Y, Kadokami T, Nakaike R, Sakata M, et al. Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. J Clin Invest 1996; 97:769 - 76; http://dx.doi.org/10.1172/JCI118476; PMID: 8609234
   PubMed Web of Science ®Google Scholar
• Bai LJ, Tuch BE, Hering B, Simpson AM. Fetal pig beta cells are resistant to the toxic effects of human cytokines. Transplantation 2002; 73:714 - 22; http://dx.doi.org/10.1097/00007890-200203150-00010; PMID: 11907416
   PubMed Web of Science ®Google Scholar
• Jana B, Kozłowska A, Andronowska A, Jedlińska-Krakowska M. The effect of tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta and IL-6 on chorioamnion secretion of prostaglandins (PG)F 2 alpha and E2 in pigs. Reprod Biol 2008; 8:57 - 68; http://dx.doi.org/10.1016/S1642-431X(12)60004-7; PMID: 18432307
   PubMed Web of Science ®Google Scholar
• Kojima F, Kato S, Kawai S. Prostaglandin E synthase in the pathophysiology of arthritis. Fundam Clin Pharmacol 2005; 19:255 - 61; http://dx.doi.org/10.1111/j.1472-8206.2005.00316.x; PMID: 15910650
   PubMed Web of Science ®Google Scholar
• Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011; 7:33 - 42; http://dx.doi.org/10.1038/nrrheum.2010.196; PMID: 21119608
   PubMed Web of Science ®Google Scholar
• Bertone AL, Palmer JL, Jones J. Synovial fluid cytokines and eicosanoids as markers of joint disease in horses. Vet Surg 2001; 30:528 - 38; http://dx.doi.org/10.1053/jvet.2001.28430; PMID: 11704948
   PubMed Web of Science ®Google Scholar
• Ritchlin C. Fibroblast biology. Effector signals released by the synovial fibroblast in arthritis. Arthritis Res 2000; 2:356 - 60; http://dx.doi.org/10.1186/ar112; PMID: 11094448
   PubMedGoogle Scholar
• Attur M, Samuels J, Krasnokutsky S, Abramson SB. Targeting the synovial tissue for treating osteoarthritis (OA): where is the evidence?. Best Pract Res Clin Rheumatol 2010; 24:71 - 9; http://dx.doi.org/10.1016/j.berh.2009.08.011; PMID: 20129201
   PubMed Web of Science ®Google Scholar
• Byron CR, Stewart MC, Stewart AA, Pondenis HC. Effects of clinically relevant concentrations of glucosamine on equine chondrocytes and synoviocytes in vitro. Am J Vet Res 2008; 69:1129 - 34; http://dx.doi.org/10.2460/ajvr.69.9.1129; PMID: 18764682
   PubMed Web of Science ®Google Scholar
• May SA, Hooke RE, Lees P. Interleukin-1 stimulation of equine articular cells. Res Vet Sci 1992; 52:342 - 8; http://dx.doi.org/10.1016/0034-5288(92)90035-Z; PMID: 1620968
   PubMed Web of Science ®Google Scholar
• Hardy J, Bertone AL, Weisbrode SE, Muir WW, O’Dorisio TM, Masty J. Cell trafficking, mediator release, and articular metabolism in acute inflammation of innervated or denervated isolated equine joints. Am J Vet Res 1998; 59:88 - 100; PMID: 9442251
   PubMed Web of Science ®Google Scholar
• Pearson W, Orth MW, Lindinger MI. Evaluation of inflammatory responses induced via intra-articular injection of interleukin-1 in horses receiving a dietary nutraceutical and assessment of the clinical effects of long-term nutraceutical administration. Am J Vet Res 2009; 70:848 - 61; http://dx.doi.org/10.2460/ajvr.70.7.848; PMID: 19566470
   PubMed Web of Science ®Google Scholar
• Sabaratnam S, Coleman PJ, Mason RM, Levick JR. Interstitial matrix proteins determine hyaluronan reflection and fluid retention in rabbit joints: effect of protease. J Physiol 2007; 578:291 - 9; http://dx.doi.org/10.1113/jphysiol.2006.119446; PMID: 17008373
   PubMed Web of Science ®Google Scholar
• Zuin S, Pojana G, Marcomini A. Effect-Oriented Physicochemical Characterization of Nanomaterials. In: Monteiro-Riviere NA, Tran CL, eds. Nanotoxicology: Characterization, Dosing and Health Effects. New York: Informa Healthcare, 2007:19-57.
   Google Scholar
• Stone V, Kinloch I. Nanoparticle Interactions with Biological Systems and Subsequent Activation of Intracellular Signaling Mechanisms. In: Monteiro-Riviere NA, Tran CL, eds. Nanotoxicology: Characterization, Dosing and Health Effects. New York: Informa Healthcare, 2007:351-68.
   Google Scholar
• Brewer SH, Glomm WR, Johnson MC, Knag MK, Franzen S. Probing BSA binding to citrate-coated gold nanoparticles and surfaces. Langmuir 2005; 21:9303 - 7; http://dx.doi.org/10.1021/la050588t; PMID: 16171365
   PubMed Web of Science ®Google Scholar
• Mahl D, Greulich C, Meyer-Zaika W, Koller M, Epple M. Gold nanoparticles: dispersibility in biological media and cell-biological effect. J Mater Chem 2010; 20:6176 - 81; http://dx.doi.org/10.1039/c0jm01071e
   Web of Science ®Google Scholar
• Kroll A, Pillukat MH, Hahn D, Schnekenburger J. Current in vitro methods in nanoparticle risk assessment: limitations and challenges. Eur J Pharm Biopharm 2009; 72:370 - 7; http://dx.doi.org/10.1016/j.ejpb.2008.08.009; PMID: 18775492
   PubMed Web of Science ®Google Scholar
• Monteiro-Riviere NA, Inman AO, Zhang LW. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol 2009; 234:222 - 35; http://dx.doi.org/10.1016/j.taap.2008.09.030; PMID: 18983864
   PubMed Web of Science ®Google Scholar
• Kroll A, Pillukat MH, Hahn D, Schnekenburger J. Interference of engineered nanoparticles with in vitro toxicity assays. Arch Toxicol 2012; 86:1123 - 36; http://dx.doi.org/10.1007/s00204-012-0837-z; PMID: 22407301
   PubMed Web of Science ®Google Scholar
• Wang G, Zhang J, Dewilde AH, Pal AK, Bello D, Therrien JM, et al. Understanding and correcting for carbon nanotube interferences with a commercial LDH cytotoxicity assay. Toxicology 2012; 299:99 - 111; http://dx.doi.org/10.1016/j.tox.2012.05.012; PMID: 22634321
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhao J, Li F, Gao D, Xing B. Adsorption and inhibition of acetylcholinesterase by different nanoparticles. Chemosphere 2009; 77:67 - 73; http://dx.doi.org/10.1016/j.chemosphere.2009.05.015; PMID: 19540550
   PubMed Web of Science ®Google Scholar
• Hyc A, Osiecka-Iwan A, Niderla-Bielinska J, Jankowska-Steifer E, Moskalewski S. Pro- and anti-inflammatory cytokines increase hyaluronan production by rat synovial membrane in vitro. Int J Mol Med 2009; 24:579 - 85; PMID: 19724900
   PubMed Web of Science ®Google Scholar
• Tammi RH, Passi AG, Rilla K, Karousou E, Vigetti D, Makkonen K, et al. Transcriptional and post-translational regulation of hyaluronan synthesis. FEBS J 2011; 278:1419 - 28; http://dx.doi.org/10.1111/j.1742-4658.2011.08070.x; PMID: 21362137
   PubMed Web of Science ®Google Scholar
• Sumbayev VV, Yasinska IM, Garcia CP, Gilliland D, Lall GS, Gibbs BF, et al. Gold nanoparticles downregulate interleukin-1β-induced pro-inflammatory responses. Small 2013; 9:472 - 7; http://dx.doi.org/10.1002/smll.201201528; PMID: 23112137
   PubMed Web of Science ®Google Scholar
• Bhattacharya R, Mukherjee P, Xiong Z, Atala A, Soker S, Mukhopadhyay D. Gold nanoparticles inhibit VEGF165-induced proliferation of HUVEC cells. Nano Lett 2004; 4:2479 - 81; http://dx.doi.org/10.1021/nl0483789
   Web of Science ®Google Scholar
• Ma JS, Kim WJ, Kim JJ, Kim TJ, Ye SK, Song MD, et al. Gold nanoparticles attenuate LPS-induced NO production through the inhibition of NF-kappaB and IFN-beta/STAT1 pathways in RAW264.7 cells. Nitric Oxide 2010; 23:214 - 9; http://dx.doi.org/10.1016/j.niox.2010.06.005; PMID: 20547236
   PubMed Web of Science ®Google Scholar
• Larsen A, Stoltenberg M, Danscher G. In vitro liberation of charged gold atoms: autometallographic tracing of gold ions released by macrophages grown on metallic gold surfaces. Histochem Cell Biol 2007; 128:1 - 6; http://dx.doi.org/10.1007/s00418-007-0295-5; PMID: 17549510
   PubMed Web of Science ®Google Scholar
• Elder RC, Zhao Z, Zhang YF, Dorsey JG, Hess EV, Tepperman K. Dicyanogold (I) is a common human metabolite of different gold drugs. J Rheumatol 1993; 20:268 - 72; PMID: 8474063
   PubMed Web of Science ®Google Scholar
• Graham GG, Dale MM. The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes--II. Evidence for the formation and biological activity of aurocyanide. Biochem Pharmacol 1990; 39:1697 - 702; http://dx.doi.org/10.1016/0006-2952(90)90113-Y; PMID: 2160818
   PubMed Web of Science ®Google Scholar
• Graham GG, Kettle AJ. The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes. III. The formation of aurocyanide by myeloperoxidase. Biochem Pharmacol 1998; 56:307 - 12; http://dx.doi.org/10.1016/S0006-2952(98)00031-8; PMID: 9744567
   PubMed Web of Science ®Google Scholar
• Yanni G, Nabil M, Farahat MR, Poston RN, Panayi GS. Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane. Ann Rheum Dis 1994; 53:315 - 22; http://dx.doi.org/10.1136/ard.53.5.315; PMID: 8017985
   PubMed Web of Science ®Google Scholar
• Yang JP, Merin JP, Nakano T, Kato T, Kitade Y, Okamoto T. Inhibition of the DNA-binding activity of NF-kappa B by gold compounds in vitro. FEBS Lett 1995; 361:89 - 96; http://dx.doi.org/10.1016/0014-5793(95)00157-5; PMID: 7890047
   PubMed Web of Science ®Google Scholar
• Yoshida S, Kato T, Sakurada S, Kurono C, Yang JP, Matsui N, et al. Inhibition of IL-6 and IL-8 induction from cultured rheumatoid synovial fibroblasts by treatment with aurothioglucose. Int Immunol 1999; 11:151 - 8; http://dx.doi.org/10.1093/intimm/11.2.151; PMID: 10069413
   PubMed Web of Science ®Google Scholar
• Nieminen R, Korhonen R, Moilanen T, Clark AR, Moilanen E. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs. Arthritis Rheum 2010; 62:1650 - 9; http://dx.doi.org/10.1002/art.27409; PMID: 20178133
   PubMed Web of Science ®Google Scholar
• Tomlinson JE, Blikslager AT. Effects of cyclooxygenase inhibitors flunixin and deracoxib on permeability of ischaemic-injured equine jejunum. Equine Vet J 2005; 37:75 - 80; http://dx.doi.org/10.2746/0425164054406865; PMID: 15651739
   PubMed Web of Science ®Google Scholar
• Hill TL. A Canine Gastric Mucosa Injury Model. Raleigh, North Carolina: North Carolina State University, 2012.
   Google Scholar
• Chang CC, Hsieh MS, Liao ST, Chen YH, Cheng CW, Huang PT, et al. Hyaluronan regulates PPARγ and inflammatory responses in IL-1β-stimulated human chondrosarcoma cells, a model for osteoarthritis. Carbohydr Polym 2012; 90:1168 - 75; http://dx.doi.org/10.1016/j.carbpol.2012.06.071; PMID: 22840054
   PubMed Web of Science ®Google Scholar
• Ross TN, Kisiday JD, Hess T, McIlwraith CW. Evaluation of the inflammatory response in experimentally induced synovitis in the horse: a comparison of recombinant equine interleukin 1 beta and lipopolysaccharide. Osteoarthritis Cartilage 2012; 20:1583 - 90; http://dx.doi.org/10.1016/j.joca.2012.08.008; PMID: 22917743
   PubMed Web of Science ®Google Scholar
• Sonavane G, Tomoda K, Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces 2008; 66:274 - 80; http://dx.doi.org/10.1016/j.colsurfb.2008.07.004; PMID: 18722754
   PubMed Web of Science ®Google Scholar
• Sonavane G, Tomoda K, Sano A, Ohshima H, Terada H, Makino K. In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. Colloids Surf B Biointerfaces 2008; 65:1 - 10; http://dx.doi.org/10.1016/j.colsurfb.2008.02.013; PMID: 18499408
   PubMed Web of Science ®Google Scholar
• Khlebtsov N, Dykman L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev 2011; 40:1647 - 71; http://dx.doi.org/10.1039/c0cs00018c; PMID: 21082078
   PubMed Web of Science ®Google Scholar
• Cho WS, Kim S, Han BS, Son WC, Jeong J. Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100 nm-sized PEG-coated gold nanoparticles. Toxicol Lett 2009; 191:96 - 102; http://dx.doi.org/10.1016/j.toxlet.2009.08.010; PMID: 19695318
   PubMed Web of Science ®Google Scholar
• Cho WS, Cho M, Jeong J, Choi M, Cho HY, Han BS, et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 2009; 236:16 - 24; http://dx.doi.org/10.1016/j.taap.2008.12.023; PMID: 19162059
   PubMed Web of Science ®Google Scholar
• Hellstern D, Schulze K, Schöpf B, Petri-Fink A, Steitz B, Kamau S, et al. Systemic distribution and elimination of plain and with Cy3.5 functionalized poly(vinyl alcohol) coated superparamagnetic maghemite nanoparticles after intraarticular injection in sheep in vivo. J Nanosci Nanotechnol 2006; 6:3261 - 8; http://dx.doi.org/10.1166/jnn.2006.482; PMID: 17048545
   PubMed Web of Science ®Google Scholar
• Barber PA, Rushforth D, Agrawal S, Tuor UI. Infrared optical imaging of matrix metalloproteinases (MMPs) up regulation following ischemia reperfusion is ameliorated by hypothermia. BMC Neurosci 2012; 13:76; http://dx.doi.org/10.1186/1471-2202-13-76; PMID: 22742423
   PubMed Web of Science ®Google Scholar
• Dykstra MJ. Manual of Applied Techniques for Biological Electron Microscopy. New York, NY: Plenum Press, 1993.
   Google Scholar